{"hands_on_practices": [{"introduction": "Competitive inhibitors are cornerstones of modern pharmacology, often designed to block the active site of a pathogenic enzyme. A fundamental skill for any biochemist or drug developer is to predict the precise concentration of such an inhibitor needed to reduce an enzyme's activity to a therapeutically effective level. This exercise [@problem_id:1979918] will guide you through the core calculation of applying the Michaelis-Menten equation for competitive inhibition to achieve a specific biological outcome.", "problem": "A team of biochemists is investigating a new drug candidate designed to act as a competitive inhibitor for a critical enzyme in a pathogenic microorganism. The enzyme is known to follow Michaelis-Menten kinetics. Through a series of initial experiments, the biochemists have characterized the enzyme's kinetic parameters under specific assay conditions. They determined the Michaelis constant, $K_M$, to be $45.0 \\ \\mu\\text{M}$ and the maximum reaction velocity, $V_{\\text{max}}$, to be $150.0 \\ \\mu\\text{M/s}$. The inhibitory potential of the drug candidate was also quantified, yielding an inhibition constant, $K_I$, of $30.0 \\ \\mu\\text{M}$.\n\nTo assess the drug's efficacy under conditions that mimic a physiological state, the team wants to determine the specific concentration of the inhibitor required to reduce the enzyme's initial reaction rate to one-quarter of its uninhibited rate. This analysis is to be conducted at a constant substrate concentration, $[S]$, equal to the enzyme's Michaelis constant, $K_M$.\n\nCalculate the required concentration of the competitive inhibitor. Express your final answer in micromolar ($\\mu\\text{M}$) and round to three significant figures.", "solution": "For Michaelis-Menten kinetics without inhibitor, the initial rate is given by\n$$\nv_{0}=\\frac{V_{\\text{max}}[S]}{K_{M}+[S]}.\n$$\nWith a competitive inhibitor at concentration $[I]$, the initial rate is\n$$\nv_{i}=\\frac{V_{\\text{max}}[S]}{K_{M}\\left(1+\\frac{[I]}{K_{I}}\\right)+[S]}.\n$$\nAt the specified condition $[S]=K_{M}$, evaluate both rates:\n$$\nv_{0}=\\frac{V_{\\text{max}}K_{M}}{K_{M}+K_{M}}=\\frac{V_{\\text{max}}}{2},\n$$\n$$\nv_{i}=\\frac{V_{\\text{max}}K_{M}}{K_{M}\\left(1+\\frac{[I]}{K_{I}}\\right)+K_{M}}=\\frac{V_{\\text{max}}K_{M}}{K_{M}\\left(2+\\frac{[I]}{K_{I}}\\right)}=\\frac{V_{\\text{max}}}{2+\\frac{[I]}{K_{I}}}.\n$$\nTo reduce the rate to one-quarter of the uninhibited rate, impose $v_{i}=\\frac{1}{4}v_{0}$:\n$$\n\\frac{V_{\\text{max}}}{2+\\frac{[I]}{K_{I}}}=\\frac{1}{4}\\cdot\\frac{V_{\\text{max}}}{2}.\n$$\nCancel $V_{\\text{max}}$ and solve for $[I]$:\n$$\n\\frac{1}{2+\\frac{[I]}{K_{I}}}=\\frac{1}{8}\\;\\Rightarrow\\;2+\\frac{[I]}{K_{I}}=8\\;\\Rightarrow\\;\\frac{[I]}{K_{I}}=6\\;\\Rightarrow\\;[I]=6K_{I}.\n$$\nSubstitute $K_{I}=30.0$ micromolar:\n$$\n[I]=6\\times 30.0=180.0.\n$$\nRounded to three significant figures, this is $1.80\\times 10^{2}$ in micromolar.", "answer": "$$\\boxed{1.80 \\times 10^{2}}$$", "id": "1979918"}, {"introduction": "In contrast to competitive inhibitors, non-competitive inhibitors bind to a secondary, or allosteric, site on the enzyme, reducing its catalytic efficiency ($V_{\\text{max}}$) without changing its affinity for the substrate ($K_M$). This mechanism makes their effect independent of substrate concentration, a crucial feature in certain therapeutic contexts. This problem [@problem_id:1979961] explores the distinct kinetics of non-competitive inhibition, challenging you to calculate the substrate concentration required to reach a target reaction rate in the presence of the inhibitor.", "problem": "A new drug is being developed to target an essential enzyme in a pathogen. The drug acts as a pure non-competitive inhibitor. In laboratory tests, this enzyme is found to follow Michaelis-Menten kinetics with a Michaelis constant, $K_M$, of $45.0 \\ \\mu\\text{M}$. The inhibitor constant, $K_I$, for the drug is determined to be $15.0 \\ \\mu\\text{M}$.\n\nThe therapeutic strategy requires reducing the enzyme's maximum possible reaction rate to 20% of its uninhibited value. To achieve this, the drug is administered at a specific constant concentration. Under these inhibitory conditions, what substrate concentration, $[S]$, is required for the enzyme to operate at a reaction rate, $v$, that is equal to 10% of the *original* (uninhibited) maximum reaction rate, $V_{\\text{max}}$?\n\nExpress your final answer for the substrate concentration $[S]$ in micromolar ($\\mu\\text{M}$) and round it to three significant figures.", "solution": "For an uninhibited Michaelis-Menten enzyme, the rate is given by\n$$\nv=\\frac{V_{\\text{max}}[S]}{K_{M}+[S]}.\n$$\nFor a pure non-competitive inhibitor at concentration $[I]$ with inhibitor constant $K_{I}$, the effect is to reduce the maximum rate by a factor $\\alpha=1+\\frac{[I]}{K_{I}}$ while leaving $K_{M}$ unchanged. Thus, under inhibition,\n$$\nv=\\frac{V_{\\text{max}}}{\\alpha}\\cdot\\frac{[S]}{K_{M}+[S]}.\n$$\nThe therapeutic condition requires the inhibited maximum rate to be $0.20$ of the original, so\n$$\n\\frac{V_{\\text{max}}}{\\alpha}=0.20\\,V_{\\text{max}}\\;\\;\\Rightarrow\\;\\;\\alpha=5\\;\\;\\Rightarrow\\;\\;1+\\frac{[I]}{K_{I}}=5\\;\\;\\Rightarrow\\;\\;[I]=4K_{I}.\n$$\nUnder these inhibitory conditions, we seek $[S]$ such that the actual rate equals $0.10$ of the original $V_{\\text{max}}$:\n$$\n\\frac{V_{\\text{max}}}{5}\\cdot\\frac{[S]}{K_{M}+[S]}=0.10\\,V_{\\text{max}}.\n$$\nCanceling $V_{\\text{max}}$ and solving for $[S]$,\n$$\n\\frac{1}{5}\\cdot\\frac{[S]}{K_{M}+[S]}=0.10\n\\;\\;\\Rightarrow\\;\\;\n\\frac{[S]}{K_{M}+[S]}=0.50\n\\;\\;\\Rightarrow\\;\\;\n[S]=0.50\\left(K_{M}+[S]\\right)\n$$\n$$\n\\Rightarrow\\;\\;[S]-0.50[S]=0.50K_{M}\n\\;\\;\\Rightarrow\\;\\;\n0.50[S]=0.50K_{M}\n\\;\\;\\Rightarrow\\;\\;\n[S]=K_{M}.\n$$\nWith $K_{M}=45.0$ micromolar, the required substrate concentration is $[S]=45.0$ micromolar.", "answer": "$$\\boxed{45.0}$$", "id": "1979961"}, {"introduction": "Before we can make quantitative predictions, we must first identify how an inhibitor works. In a real-world research scenario, the mechanism of a newly discovered compound is unknown and must be determined experimentally. By analyzing how reaction rates change in response to varying substrate concentrations, with and without the inhibitor, we can deduce its mode of action. This practice [@problem_id:1432075] simulates this crucial diagnostic process, asking you to interpret raw kinetic data to identify the inhibition mechanism at play.", "problem": "A team of biochemists is developing a new drug candidate, \"Compound Y-31,\" intended to treat a metabolic disorder caused by the over-activity of a specific enzyme, Fumarate-Malate Dehydrogenase (FMDH). To characterize the interaction of Compound Y-31 with FMDH, they conducted a series of kinetic experiments. The initial reaction velocity ($v_0$) was measured at various concentrations of the substrate, fumarate ($[S]$), both in the absence and in the presence of a fixed concentration of Compound Y-31. The collected data are presented in the table below.\n\n| Substrate Concentration, $[S]$ ($\\mu\\text{M}$) | Initial Velocity without Inhibitor, $v_0$ ($\\mu\\text{M}/\\text{min}$) | Initial Velocity with Inhibitor, $v_0$ ($\\mu\\text{M}/\\text{min}$) |\n|:---:|:---:|:---:|\n| 2.0 | 16.7 | 7.4  |\n| 5.0 | 33.3 | 16.7 |\n| 10.0| 50.0 | 28.6 |\n| 20.0| 66.7 | 44.4 |\n| 50.0| 83.3 | 66.7 |\n\nBased on these experimental data, determine the mechanism of inhibition that Compound Y-31 exerts on the FMDH enzyme.\n\nA. Competitive inhibition\n\nB. Non-competitive inhibition\n\nC. Uncompetitive inhibition\n\nD. Substrate inhibition\n\nE. No inhibition", "solution": "We assume Michaelis–Menten kinetics. The initial velocity as a function of substrate concentration is\n$$\nv=\\frac{V_{\\text{max}}[S]}{K_{M}+[S]}.\n$$\nFirst determine $V_{\\text{max}}$ and $K_{M}$ from the data without inhibitor. Using two data points:\n- At $[S]=10$, $v=50$:\n$$\n50=\\frac{V_{\\text{max}}\\cdot 10}{K_{M}+10}\\;\\Rightarrow\\;V_{\\text{max}}=5\\left(K_{M}+10\\right).\n$$\n- At $[S]=20$, $v=66.7$. Interpreting the recurring decimal $66.7$ as $66.\\overline{6}=\\frac{200}{3}$,\n$$\n\\frac{200}{3}=\\frac{V_{\\text{max}}\\cdot 20}{K_{M}+20}\\;\\Rightarrow\\;V_{\\text{max}}=\\frac{200}{3}\\cdot\\frac{K_{M}+20}{20}=\\frac{10}{3}\\left(K_{M}+20\\right).\n$$\nEquating the two expressions for $V_{\\text{max}}$,\n$$\n5\\left(K_{M}+10\\right)=\\frac{10}{3}\\left(K_{M}+20\\right)\\;\\Rightarrow\\;15K_{M}+150=10K_{M}+200\\;\\Rightarrow\\;5K_{M}=50\\;\\Rightarrow\\;K_{M}=10,\n$$\nand then\n$$\nV_{\\text{max}}=5\\left(10+10\\right)=100.\n$$\n\nNow analyze the inhibited data. For competitive inhibition at fixed inhibitor concentration $[I]$, the Michaelis–Menten form is\n$$\nv=\\frac{V_{\\text{max}}[S]}{\\alpha K_{M}+[S]},\\quad \\alpha=1+\\frac{[I]}{K_{i}},\n$$\nso $V_{\\text{max}}$ is unchanged and the apparent Michaelis constant is $K_{M,\\text{app}}=\\alpha K_{M}$. Using $V_{\\text{max}}=100$ and one inhibited datapoint to solve for $K_{M,\\text{app}}$:\n- At $[S]=50$, $v=66.7=66.\\overline{6}=\\frac{200}{3}$,\n$$\n\\frac{200}{3}=\\frac{100\\cdot 50}{K_{M,\\text{app}}+50}\\;\\Rightarrow\\;K_{M,\\text{app}}+50=\\frac{5000}{200/3}=75\\;\\Rightarrow\\;K_{M,\\text{app}}=25.\n$$\nCheck consistency at another substrate concentration:\n- At $[S]=20$, prediction with $V_{\\text{max}}=100$, $K_{M,\\text{app}}=25$ is\n$$\nv=\\frac{100\\cdot 20}{25+20}=\\frac{2000}{45}=\\frac{400}{9}=44.\\overline{4},\n$$\nwhich matches the reported $44.4$. Similarly, at $[S]=10$ the prediction is $v=\\frac{100\\cdot 10}{25+10}=\\frac{1000}{35}=\\frac{200}{7}\\approx 28.6$, at $[S]=5$ it is $v=\\frac{500}{30}=\\frac{50}{3}=16.\\overline{6}$, and at $[S]=2$ it is $v=\\frac{200}{27}=7.\\overline{407}$, all matching the inhibited data.\n\nThus, the inhibited data are exactly described by $V_{\\text{max}}$ unchanged at $100$ and $K_{M}$ increased from $10$ to $25$, i.e., $K_{M,\\text{app}}=\\alpha K_{M}$ with $\\alpha=\\frac{25}{10}=2.5$, which is the hallmark of competitive inhibition. Alternative mechanisms are inconsistent: non-competitive inhibition would decrease $V_{\\text{max}}$ with $K_{M}$ unchanged, and uncompetitive inhibition would decrease both $V_{\\text{max}}$ and $K_{M}$ in the same proportion; neither matches the observed parameter changes.", "answer": "$$\\boxed{A}$$", "id": "1432075"}]}